Purchases and Sales Made in Q2 2023 in Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV) during Q2 2023. The information is specifically focused on institutions that hold shares of Verve Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-287K- 8.56% |
$3.83M - $5.71M
|
3.06M
$26.3M
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-404K- 81.87% |
$5.4M - $8.05M
|
89.5K
$768K
|
|
|
Aug 14, 2023
Q2 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-473K- 35.0% |
$6.31M - $9.41M
|
879K
$7.54M
|
|
|
Aug 14, 2023
Q2 2023
|
Novo Holdings
Hellerup, G7 |
SELL
|
- |
-700K- 58.33% |
$9.34M - $13.9M
|
500K
$4.29M
|